Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Blocking IL-8 can reduce skin rashes from cancer treatment.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

More precise, personalized therapies are needed for autoimmune diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.